Michelle Fransen

Nov 19, 2024 | onlinelibrary.wiley.com | Michelle Fransen |Toby Simon |James Knowles |Joshua Penrod

Recent publications have questioned the importance of the Plasma Protein Therapeutics Association's (PPTA) results as they relate to source plasma (SP) donor health. A commentary published in Transfusion by Van Remoortel et al. states that the ‘very-low-quality evidence … should not be used to substantiate claims regarding the safety of repeated plasmapheresis’ [1].

Aug 25, 2023 | onlinelibrary.wiley.com | Mark Becker |Michelle Fransen |Janet Hershman |James Lenart

Abbreviations FDA Food and Drug Administration HFD high frequency donors HNP health issues not related to or not likely related to plasmapheresis HP health issues possibly related to or unable to determine relationship to plasmapheresis IgG immunoglobulin LFD low frequency donors ND new donors PDHS plasma donor health study PDMP plasma-derived medicinal products PPTA plasma protein therapeutics association SP source plasma US United States VHFD very high frequency donors 1 INTRODUCTION Source...